ArticleOncology letters2025

Prognostic value of inflammation- and nutrition-based biomarkers in patients with recurrent or metastatic oral squamous cell carcinoma treated with immune checkpoint inhibitors: A retrospective study.

Sachiko Yamasaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.